Table 1.
Participant characteristics.
| Demographic Variable | N=159 |
|---|---|
| Age, mean (SD) | 35.8 (11.4) |
| Women, No. (%) | 103 (65.6%) |
| Race/Ethnicity, No. (%) | |
| African American | 13 (8.4%) |
| Asian American | 20 (12.9%) |
| Caucasian | 100 (64.5%) |
| Hispanic | 10 (6.5%) |
| Other/Biracial | 12 (7.8%) |
| Employment Status, No. (%) | |
| Full Time/Part Time | 87 (56.9%) |
| Unemployed/Retired/Disability | 66 (43.1%) |
| Marital Status, No. (%) | |
| Married/Partnered | 33 (20.9%) |
| Separated/Divorced/Widowed | 27 (17.1%) |
| Single | 98 (62.0%) |
| Annual Income, No. (%) | |
| Less than $50,000 | 95 (73.6%) |
| Greater than $50,000 | 34 (26.4%) |
| IDS-C Total Score, mean (SD) | 11.7 (7.6) |
| YMRS Total Score, mean (SD) | 3.3 (2.9) |
| Psychotropic Medications, No. (%) | |
| None | 10 (6.3%) |
| Monotherapy | 35 (22.0%) |
| Polytherapy | 114 (71.7%) |
| Mood Stabilizers/Anticonvulsants | 96 (60.4%) |
| Antidepressants | 85 (53.5%) |
| Atypical Antipsychotics | 77 (48.4%) |
| Typical Antipsychotics | 2 (1.3%) |
| Anxiolytics | 36 (22.6%) |
| Stimulants | 9 (5.7%) |
| Sleep/Hypnotics | 37 (23.3%) |